Abstract
The 65-kDa oncofetal protein (p65), a novel tumor marker (1–7), is highly conserved m different species (2,4). We have identified the p65 gene as a novel member of the family of genes that encode receptors for steroid hormones, vitamin D, retmoic acid and thyroid hormone (7). The p65 protein is highly homologous to estrogen receptor (ER) m its DNA binding domain but other regions of the sequence do not show similarities, indicating that p65 is a new transcription factor or receptor with an as yet unknown ligand. Using enzymelmked immunosorbent assay (ELISA) and immunostaining, p65 was shown (5,6), to be a promismg marker for diagnosis and prognosis of cancer. With a view toward early detection of cancer, we have studied strain-dependent differences in the expression of p65 in different organs of mice highly susceptible (C3H/HeJ) and relatively resistant (C57BL/6N) to carcinogenesis. In this chapter, we describe a new, general procedure for detection of p65 mRNA by reverse transcription polymerase chain reaction (RT-PCR). This method is sensitive enough to detect a small number of the p65-specific mRNA molecules in mammary glands and livers of young, 7–8 wk-old female mice of the C3H/HeJ strain are known to spontaneously develop mammary tumors and be sensitive to liver tumor induction. No p65-specific mRNA was detected in a control group of C57BL/6N mice known to be resistant to chemical carcmogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanausek-Walaszek M., Del Rio M., and Adams A K. (1989) Immunohlstochemical demonstration of mRNA-transport protein in rat liver putative preneoplastic foci. Cancer Lett 48, 105–108.
Hanausek-Walaszek M, Del Rio M, and Adams A K. (1990) Structural and immunological identity of p65 tumor-associated factors from rat and mouse hepatocarcmomas. Progr Cfin Bzol Res 331, 109–120.
Mirowski M, Sherman U, and Hanausek M (1992) Purification and characterization of a 65-kDa tumor-associated phosphoprotem from rat transplantable hepatocellular carcinoma 1682C cell line. Protein Expr Purif 3, 196–203
Mirowskl M., Walaszek Z, Sherman U., Adams A. K, and Hanausek M (1993) Comparative structural analysis of human and rat 65 kDa phosphoprotein Int J Blochem 25, 1865–1871
Wang S., Mirowski M., Sherman U., Walaszek Z., and Hanausek M. (1993) Monoclonal antibodies against a 65 kDa tumor-associated phosphoprotem development and use in cancer detection. Hybridoma 12, 167–176.
Mirowski M., Klijanienko J., Wang S., Vielh P., Walaszek Z, and Hanausek M (1994) Serological and immunohistochemical detection of a 65 kDa protein breast cancer Eur J Cancer 30A, 1108–1113
Hanausek M, SzemraJ J., Adams A. K., and Walaszek Z. (1996) The oncofetal protein p65. a new member of the steroid/thyroid receptor superfamily Cancer Detect Prev 20, 94–102.
Bennet L M., Famham P. J., and Drinkwater N R. (1995) Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of C57B1/6J and C3H/HeJ mice Moi Carcinogenesis 14, 46–52
Drinkwater N R. and Ginsler J. J (1986) Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcmogenesis 7, 1701–1707.
Bennett L. M., Winkler M. L, and Drinkwater N. R. (1993) A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc Am Assoc Cancer Res 33, 144
Gariboldi M., Manenti G., Canzian F., Falvella S., Pierotti M, Della Porta G., and Dragani T. A (1993) Chromosomal mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53, 209–211.
Manenti G, Binelli G, Gariboldi M, Canzian F, De Gregoriol R, Flavella S, Dragani T. A., and Pierotti M (1994) Multiple loci affect genetic predispositton to hepatocarcinogenesis in mice Genomics 23, 118–124
Medina D (1976) Preneoplastic lesions in murine mammary cancer Cancer Res 36, 2589–2595
Schwartz M S., Smith G H., and Medina D. (1992) The effect of parity, tumor latency and transplantation of the activation of int loct in MMTV-induced, transplantal C3H mammary neoplasias and their tumors. Int J Cancer 51, 805–811.
Dux A (1981) Sensitivity of the mammary gland to tumor formation, in Mammary Tumors in the Mouse (Hilgers J. and Skryser M., eds.), Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands, 516–543
Festing M F. W. and Blackmore D. K. (1971) Life span of specified-pathogen-free (MRC category 4) mice and rats Lab Anlm (Lond) 5, 179–192
Burmer G C. and Loeb L A. (1989) Mutations in the K-ras 2 oncogene during progressive stages of human colon carcinoma. Proc Natl. Acad. Sci USA 86, 2403–2407
Burmer G. C, Parker J D, Bates J, East K., and Kulander B G (1990) Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype Am J Clin Pathol 94, 554–560
Burmer G. C., Rabinovitch P S, and Loeb L. A. (1989) Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction and DNA sequencing. Cancer Res. 49, 214l–2146.
Frohman M. A., Dush M K., and Martin G. R (1988) Rapid productton of full-length cDNAs from rare transcripts. amplification using single gene specific oligonucleotide primer. Proc Nat1 Acad Scl USA 85, 8998–9002
Higuchi R, von Beroldingen C H, Sensabaugh G F, and Erlich H A. (1988) DNA typing from single hairs Nature 333, 543-540
Saiki R K, Gelfand D H, Stoffel S., Scharf S J., Higuchi R, Horn G. T, Mullis K B., and Erlich H. A (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Sczence 39, 487–491.
Erlich H. A (1989) PCR Technology Prlnclples and Appllcatlons for DNA Amplrjkatton. Stockton, New York.
Ponce R. P and Micol J L (1992) PCR amplification of long DNA fragments Nucleic Acids Res 20, 3–623
D’Aquaila R. T., Bechtel L. J, Videler J A., Eron J J., Gorczyca P, and Kaplan J. C. (1991) Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 19, 3749–3754
Hanausek-Walaszek M, Adams A. K., and Sherman U. (1991) Expression of a 65 kda tumor-associated protein and persistence of altered hepatic faci. Progr Clm Blol Res 369, 91–103
Hanausek M., Sherman U., Mirowski M, and Walaszek Z Induction of a 65 kDa tumor-associated protein in altered hepatic foci of rats fed the peroxisome proliferator Wy-14,643 Progr Clan Biol Res 387, 337–348
Ponglikitmongkol M., Green S., and Chambon P (1988) Genomic organization of the human oestrogen receptor gene EMBO J 7, 3385–3388
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Szemraj, J., Hanausek, M., Walaszek, Z., Adams, A.K. (1998). Strain-Dependent Differences in the Expression of the Oncofetal Protein p65 in Mice Susceptible and Resistant to Chemical Carcinogenesis. In: Hanausek, M., Walaszek, Z. (eds) Tumor Marker Protocols. Methods in Molecular Medicine™, vol 14. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-380-5:475
Download citation
DOI: https://doi.org/10.1385/0-89603-380-5:475
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-380-1
Online ISBN: 978-1-59259-598-3
eBook Packages: Springer Protocols